Form 4: Teladoc Health Executive Waters Reports Stock Transactions
SEC Form 4 Filing
Michael Willem Waters, Chief Operating Officer of Teladoc Health, reports the acquisition and disposal of company stock and derivative securities.
Summary
- Michael Willem Waters, the Chief Operating Officer of Teladoc Health, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On May 31, 2024, Waters acquired 2,113 shares of common stock through the conversion of performance stock units and 6,200 shares through the conversion of restricted stock units.
- On June 3, 2024, Waters sold 4,246 shares of common stock at a price of $11.157 per share.
- Following these transactions, Waters directly owns 68,948 shares of Teladoc Health common stock and holds 14,792 performance stock units and 43,404 restricted stock units.
- The sale of shares was to cover tax withholding obligations related to the vesting of performance stock units and restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may use this information to assess the actions of company leadership.
Key Dates
| Date | Description |
|---|---|
| 03/03/2023 | Reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/01/2024 | The reporting person earned 25,357 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 05/31/2024 | Acquisition of 2,113 shares of common stock through conversion of performance stock units. |
| 05/31/2024 | Acquisition of 6,200 shares of common stock through conversion of restricted stock units. |
| 06/03/2024 | Sale of 4,246 shares of common stock at $11.157 per share. |
| 06/04/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.